8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General0

Microwave dynamic therapy induces ferroptosis in colorectal cancer by targeting PTK2B to regulate STAT3-mediated GPX4 expression

Bioeffects Seen

Zhou H, Zhang Z, Liu Z, Xiong L, Ran X, Liu J, Ran Y, Wen Y, Chen W, Xu J · 2025

Share:

Controlled microwave therapy can kill colorectal cancer cells through ferroptosis, but therapeutic applications differ fundamentally from uncontrolled everyday EMF exposures.

Plain English Summary

Summary written for general audiences

Researchers discovered that microwave dynamic therapy (MWDT) kills colorectal cancer cells through ferroptosis, a specific type of cell death caused by iron buildup and oxidative damage. The microwaves work by disrupting a molecular pathway (PTK2B/STAT3/GPX4) that normally protects cancer cells from this iron-dependent death. This finding suggests microwave therapy could offer a low-toxicity alternative to traditional chemotherapy for colorectal cancer patients.

Why This Matters

This study represents a fascinating intersection of microwave technology and cancer biology. While we typically discuss EMF exposures in terms of unintended health risks from everyday devices, this research explores therapeutic microwave applications that deliberately target cancer cells. The science demonstrates that controlled microwave exposure can trigger ferroptosis in colorectal cancer by manipulating specific cellular pathways, particularly the PTK2B/STAT3/GPX4 axis that protects cells from iron-induced oxidative damage.

What matters here is context and dosage. Therapeutic microwave applications use precisely controlled frequencies, intensities, and exposure durations designed to kill cancer cells while minimizing damage to healthy tissue. This differs fundamentally from chronic, uncontrolled EMF exposure from phones, WiFi, and other consumer devices. The research adds nuance to our understanding that electromagnetic fields are not universally harmful or beneficial. Rather, biological effects depend critically on exposure parameters, duration, and cellular context. This doesn't validate casual high-level exposures in daily life, but it does reinforce that we must distinguish between deliberate therapeutic applications under medical supervision and involuntary environmental exposures that lack such controls.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Zhou H, Zhang Z, Liu Z, Xiong L, Ran X, Liu J, Ran Y, Wen Y, Chen W, Xu J (2025). Microwave dynamic therapy induces ferroptosis in colorectal cancer by targeting PTK2B to regulate STAT3-mediated GPX4 expression.
Show BibTeX
@article{zhou_h_zhang_z_liu_z_xiong_l_ran_x_liu_j_ran_y_wen_y_chen_w_xu_j_ce2661,
  author = {Zhou H and Zhang Z and Liu Z and Xiong L and Ran X and Liu J and Ran Y and Wen Y and Chen W and Xu J},
  title = {Microwave dynamic therapy induces ferroptosis in colorectal cancer by targeting PTK2B to regulate STAT3-mediated GPX4 expression},
  year = {2025},
  doi = {10.1186/s43556-025-00322-2},
  
}
DOI: 10.1186/s43556-025-00322-2

Quick Questions About This Study

Microwave dynamic therapy (MWDT) is an emerging cancer treatment that uses controlled microwave exposure to kill cancer cells. In this study, MWDT induced ferroptosis, an iron-dependent form of cell death, by disrupting protective cellular mechanisms. It showed effectiveness against colorectal cancer both in laboratory cultures and animal models.
MWDT inhibits the PTK2B protein, which prevents STAT3 activation and ultimately reduces GPX4 expression. GPX4 normally protects cells from lipid peroxidation and iron damage. Without sufficient GPX4, cancer cells accumulate reactive oxygen species, iron, and damaged lipids, leading to ferroptotic cell death.
MWDT treatment significantly increased lipid peroxidation, reactive oxygen species (ROS), malondialdehyde (MDA), and ferrous iron (Fe2+) levels in colorectal cancer cells. Simultaneously, glutathione (GSH), which protects against oxidative damage, decreased significantly. Ferrostatin-1, a ferroptosis inhibitor, partially reversed these changes.
PTK2B interacts with and activates STAT3 through phosphorylation. Activated STAT3 moves into the cell nucleus where it binds to the GPX4 gene promoter and increases GPX4 production. GPX4 protects cancer cells from ferroptosis. MWDT disrupts this protective pathway by inhibiting PTK2B.
This preclinical research demonstrates that controlled microwave exposure can kill colorectal cancer cells through ferroptosis. However, this occurred under specific laboratory conditions with precise parameters. The findings support further investigation of MWDT as a potential low-toxicity cancer therapy, but clinical trials are needed.